CXADR is a Human IgG Fc Receptor
Emig, C. J.; Vitug, A. A.
Show abstract
CXADR is a membrane protein present in epithelial tight junctions and other tissues with a variety of known functions, in addition to its role as entry receptor for coxsackie B virus and adenovirus 2 and 5. We identified a previously unknown function of CXADR as a binding partner for human IgG but not IgA, IgE, IgM, or ScFv in a non paratope specific manner. Binding was specific to human and rabbit IgG, and not observed for mouse, rat, donkey, or goat IgG. Binding of Ig to CXADR is inhibited by FcBlock (BD), and is competitive with anti-Fc binding secondary antibodies, but not anti-Fab secondary antibodies, indicating that CXADR binds the Fc portion of IgG. CXADR, being a member of the immune superfamily of proteins, has similar structural homology to other Ig binding proteins, including Fc receptors. We conclude that CXADR has a previously unknown function as a human Fc receptor, serving as a direct link between the humoral adaptive immune system and many cell types in the human body previously unknown to express FcR.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Opsonization by non-neutralizing antibodies can confer protection to SARS-CoV-2 despite Spike-dependent modulation of phagocytosis 95%
- Human Fcγ-receptors selectively respond to C-reactive protein (CRP) isoforms 93%
- Novel ELISA protocol links pre-existing SARS-CoV-2 reactive antibodies with endemic coronavirus immunity and age and reveals improved serologic identification of acute COVID-19 via multi-parameter detection 93%
Similar papers in this journal
- Highly versatile antibody binding assay for the detection of SARS-CoV-2 infection 91%
- Performance and validation of an adaptable multiplex assay for detection of serologic response to SARS-CoV-2 infection or vaccination 91%
- Multiplex ACE2-RBD Binding Inhibition Assay: An Integrated Tool for Assessing Neutralizing Antibodies to SARS-CoV-2 Variants and Protection against Breakthrough Infections 91%
Similar papers in this journal
- No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor 93%
- Reduced serum neutralization capacity against SARS-CoV-2 variants in a multiplex ACE2 RBD competition assay 93%
- Choice of lipid supplementation for in vitro erythroid cell culture impacts reticulocyte yield and characteristics 92%
Similar papers in this journal
- C1q/MASP complexes - hybrid complexes of classical and lectin pathway proteins are found in the circulation 94%
- Expansion of SARS-CoV-2-specific Antibody-secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients 92%
- Choice of host cell line is essential for the functional glycosylation of the fragment crystallizable (Fc) region of human IgG1 inhibitors of influenza B viruses 91%
Similar papers in this journal
- Siglec-5 is an inhibitory immune checkpoint molecule for human T cells 92%
- ERAP1 allotypes 2 and 10 differentially regulate the immunopeptidome of melanocytes 92%
- Whole blood-based measurement of SARS-CoV-2-specific T cell responses reveals asymptomatic infection and vaccine efficacy in healthy subjects and patients with solid organ cancers 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.